New clinical trial is now recruiting in Boston


A new Phase II clinical trial targeting angiosarcoma is now recruiting patients at Boston’s Massachusetts General Hospital and the Dana-Farber Cancer Institute. For details on this and other available trials, check out the recently updated clinical trials page of our website, which is located under our Resources section.